Bruce Booth - Profile and Investment Details

Investor Profile

Bruce Booth is a Venture Capital, Private Equity Firm, Angel/Individual based in Wellesley, Massachusetts, United States with a diverse investment portfolio that includes companies such as Nimbus Therapeutics, Magenta Therapeutics, Vigil Neuroscience, Quartet Medicine, Numerate, Inc., Bicycle Therapeutics, HotSpot Therapeutics, Inc.Miragen Therapeutics, UNUM Therapeutics, Kymera Therapeutics, Avrobio, Viridian Therapeutics, Lysosomal Therapeutics Inc, Matchpoint Therapeutics, Arkuda Therapeutics, Rodin Therapeutics, miRagen Therapeutics, Inc., Sionna Therapeutics, Zafgen, Incorporated, Stromedix, Larimar Therapeutics, Avila Tx, Quench Bio, Cogent Biosciences, Padlock Therapeutics, . Over time, Bruce Booth has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Bruce Booth is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Healthcare Delivery, Wellness, Immunotherapy, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Startups, Finance, Bioinformatics, Biotechnology, Consumer Health, Drug Development, Health and Hospital Services, Precision Medicine, Clinical Trials, Gene Therapy, Technology Transfer, Medical, Information Technology, B2B, Therapeutics, Cellular Therapy, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Bruce Booth, as their portfolio suggests a familiarity and interest in this area.

Understanding Bruce Booth’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.